Chen, Liqiao
Yang, Xuesong
Zhu, Peiyu
Bao, Han
Wu, Yan
Ji, Ke
Zhang, Ji
Wu, Xiaojiang
Zhou, Kai
Xu, Jieli
Tang, Jiatian
Wang, Anqiang
Bu, Zhaode
Funding for this research was provided by:
National Key Research and Development Program of China (No.2023YFF1204700, branch No.2023YFF1204702)
Article History
Received: 30 July 2025
Accepted: 30 October 2025
First Online: 22 December 2025
Declarations
:
: The study of human samples was performed according to the Declaration of Helsinki and Good Clinical Practice. The protocol of this research and the license for usage of clinical data were given by the Ethics Committee of Peking University Cancer Hospital and Institute (code 2024KT174). All patients signed informed consent forms.
: The authors declare no competing interests.